Company snapshot
Market Cap
$8B
Mid-cap2016 — today
10-Year Price
+186%
2016 — today
52-Week Range
$73.21$106.79
Current $96.07· 68%
Featured in rankings
Most Undervalued Healthcare StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Growth StocksBest GARP Stocks (Growth at a Reasonable Price)GARP Universe
Rankings recomputed after each US market close — see where HQY stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ZTSZoetis Inc. | 12.5 | 2.8% |
| CNCCentene Corporation | -6.4 | — |
| ALCAlcon Inc. | 54.2 | 0.5% |
| ALNYAlnylam Pharmaceuticals, Inc. | 45.0 | — |
| ONCBeOne Medicines Ltd. | 5.0 | — |
| AAgilent Technologies, Inc. | 29.7 | 0.5% |
| TEVATeva Pharmaceutical Industries Limited | 60.6 | — |
| IDXXIDEXX Laboratories, Inc. | 37.9 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
34.7
Historically cheap
Historically cheap relative to the last 10 years
Sector median 25.5above sector
P/B ratio
4.1
Above average
Pricier than usual over the last 10 years
Sector median 2.6above sector
EV / EBITDA
16.7
Near historic low
Near historic low — last 10 years
Sector median 15.7in line with sector
PEG ratio
0.2
Near historic low
Near historic low — last 10 years
Sector median 1.5below sector
FCF Yield
5.8%
Near historic high
Near historic highs — last 10 years
Sector median -9.4%above sector